Clinical Trial Update: Vaccination by Leukemic Apoptotic Corpse Autologous Pulsed Dendritic Cells for Acute Myelogenous Leukemia (AML) Patients in First or Second Complete Remission (CR)(CD laM) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial investigating an autologous dendritic cell vaccine pulsed with leukemic apoptotic material for acute myeloid leukemia patients in fir…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Autologous leukemic apoptotic corpse dendritic cell vaccine (autologous dendritic cell vaccine pulsed with leukemic apoptotic corpse material)

Snippet

Sponsor: Nantes University Hospital | Conditions: Acute Myelogenous Leukemia | Phase 1, Phase 2 | Status: UNKNOWN